The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo
Novel germline mutations inBRCA2gene among 96 hereditary breast and breast–ovarian cancer families from Kerala, South India
✍ Scribed by Vani Syamala; Leelakumari Sreeja; Volga S. Syamala; B. Vinodkumar; Praveenkumar B. Raveendran; Hariharan Sreedharan; Ratheesan Kuttappan; Lekshmi Balakrishnan; Ravindran Ankathil
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 401 KB
- Volume
- 133
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Communicated by Mark H. Paalman Germline mutations in breast cancer susceptibility genes, BRCA1 and BRCA2, are responsible for a substantial proportion of high-risk breast and breast/ovarian cancer families. To characterize the spectrum of BRCA1 and BRCA2 mutations, we screened Czech families w
Germline mutations in the BRCA1 and BRCA2 genes account for the majority of high-risk breast/ovarian cancer families, depending on the population studied. Previously, BRCA1 mutations were described in women from Western Poland. To further characterize the spectrum of BRCA1 mutations and the impact o
Two potential breast cancer susceptibility genes, encoding the BRCA1-interacting proteins ZNF350 (or ZBRK1) and BRIP1 (or BACH1), have been identified in yeast two-hybrid screens. We sequenced these genes in probands from 21 families with potentially inherited breast/ovarian cancer, all of which wer